Literature DB >> 12103306

Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs.

James Shepherd1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12103306     DOI： 10.1016/S0140-6736(02)09299-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Strategies for statins: The CASE for fire and forget.

Authors:  L Sam Lewis
Journal:  BMJ       Date:  2008-02-23

2.  Strategies for prescribing statins.

Authors:  Norbert Donner-Banzhoff; Andreas Sönnichsen
Journal:  BMJ       Date:  2008-02-09

3.  Are the new guidelines for the use of lipid-lowering agents sound, and should their adoption be encouraged?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2014-05

Review 4.  Evolution of lipid management guidelines: evidence might set you free.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2014-07       Impact factor: 3.275

5.  Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy.

Authors:  Joshua S Benner; Jonothan C Tierce; Christie M Ballantyne; Cheryl Prasad; Michael F Bullano; Vincent J Willey; John Erbey; David S Sugano
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 6.  Practical use of the Framingham risk score in primary prevention: Canadian perspective.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2011-04       Impact factor: 3.275

7.  Lack of Awareness of Own Hypercholesterolemia or Statin Medication among Adult Statin Users in the United States: Prevalence and Patient Characteristics in a Repeated Cross-Sectional Study.

Authors:  Kenjiro Imai; Takehiro Sugiyama; Mitsuru Ohsugi; Masafumi Kakei; Kazuo Hara
Journal:  Int J Environ Res Public Health       Date:  2022-05-17       Impact factor: 4.614

Review 8.  Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2013-11       Impact factor: 3.275

9.  Higher baseline lipid levels amplify the benefit of secondary prevention therapy with statins in Chinese patients with acute coronary syndrome.

Authors:  Ling Zhu; Ying Liu; Wei Zhang; Zhu Zhang; Liqin Zhou; Hong Zhang; Yong Zhang; Fuqiang Liu; Peng Liu; Zhongwei Liu; Junkui Wang
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.